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A microfluidic device for measuring 
cell migration towards substrate-
bound and soluble chemokine 
gradients
Jan Schwarz1, Veronika Bierbaum1, Jack Merrin1, Tino Frank2, Robert Hauschild1, 
Tobias Bollenbach1,†, Savaş Tay2,3, Michael Sixt1 & Matthias Mehling1,4
Cellular locomotion is a central hallmark of eukaryotic life. It is governed by cell-extrinsic molecular 
factors, which can either emerge in the soluble phase or as immobilized, often adhesive ligands. To 
encode for direction, every cue must be present as a spatial or temporal gradient. Here, we developed 
a microfluidic chamber that allows measurement of cell migration in combined response to surface 
immobilized and soluble molecular gradients. As a proof of principle we study the response of dendritic 
cells to their major guidance cues, chemokines. The majority of data on chemokine gradient sensing 
is based on in vitro studies employing soluble gradients. Despite evidence suggesting that in vivo 
chemokines are often immobilized to sugar residues, limited information is available how cells respond 
to immobilized chemokines. We tracked migration of dendritic cells towards immobilized gradients 
of the chemokine CCL21 and varying superimposed soluble gradients of CCL19. Differential migratory 
patterns illustrate the potential of our setup to quantitatively study the competitive response to both 
types of gradients. Beyond chemokines our approach is broadly applicable to alternative systems of 
chemo- and haptotaxis such as cells migrating along gradients of adhesion receptor ligands vs. any 
soluble cue.
The ability of cells to migrate is fundamental to many physiological processes, such as embryogenesis, regen-
eration, tissue repair and protective immunity1. Cell migration is mainly governed by adhesion of cells to sub-
strates (other cells or connective tissue) and by extracellular signalling molecules acting as motogenic stimuli 
or directional guidance cues2. The specific impact of these factors differs considerably between cell types. While 
mesenchymal and epithelial cells are dominated by adhesive interactions the amoeboid crawling of leukocytes 
is largely controlled by guidance cues of the chemokine family3,4. The prevailing paradigm of chemokine func-
tion is that spatial diffusion-based gradients of chemokines induce polarization and directed migration of the 
responding cells towards the chemokine source5. However, the scarce information available for in vivo chemokine 
gradients suggests that the situation is often more complex and that chemokines are unlikely to distribute by free 
diffusion only. Like most growth factors chemokines bind to different degrees to cell surface or connective tissue 
glycosaminoglycans6–8. Such interactions restrict chemokine distribution and thereby can shape gradients. For 
chemokines binding with high affinity to sugar residues, immobilization can even lead to the formation of stable 
solid phase gradients, which induce a variant of haptotaxis9. Although it is conceivable that cells can equally 
respond to gradients of soluble and/or immobilized chemokines, almost all cell biological information available 
about-gradient sensing is based on in vitro studies employing soluble gradients.
The best understood example for the significance of immobilized vs. soluble chemokine gradients is the 
trafficking of dendritic cells (DCs). After having captured antigen in non-lymphoid tissues, DCs migrate along 
immobilized gradients of the high affinity sugar-binding chemokine (C-C motif) ligand21 (CCL21) towards 
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lymphatic vessels, from where they are flushed into the sinus of lymph nodes. Once in the lymph node, the 
cells experience a second chemokine, (C-C motif) ligand19 (CCL19), which interacts with the same receptor 
(C-C chemokine receptor 7, CCR7) but interacts only weakly with sugars. It has been shown in vitro that the 
directionality of DCs migrating on homogenously immobilized CCL21 can be biased by gradients of soluble 
CCL1910. When exposed to competing soluble gradients of CCL19 and CCL21, DCs displayed higher sensitivity 
towards CCL1911. In contrast, if CCL21 diffusion was influenced by unspecific binding to charged extracellular 
matrix components, CCL21 induced directionality prevailed when opposed by a soluble CCL19 gradient12. How 
DCs respond to immobilized and co-existing immobilized and soluble chemokine gradients remains elusive.
Here we developed an in vitro setup to study the significance and interaction of co-existing bound and soluble 
chemokine gradients for directed cell migration. To this end we engineered a microfluidic device to generate 
diffusion-based chemokine gradients, which allows simultaneous surface-immobilization of arbitrarily graded 
chemokine patterns. We used DCs as a model to track migration in response to soluble and immobilized chemok-
ine on a single cell level in real time.
Results and Discussion
Microfluidic system to probe chemotactic and haptotactic migration at the single cell level. To 
quantitatively track immune cell migration in simultaneous response to chemotactic and haptotactic gradients 
we developed a microfluidic device that allows (i) patterning of bound chemokine gradients, (ii) precise posi-
tioning of immune cells on these haptotactic gradients and (iii) the generation of diffusion-based (flow-free) 
soluble chemokine gradients superimposed on haptotactic gradients in small microfluidic migration chambers. 
Specifically, the two-layer PDMS microfluidic device (overview in Fig. 1a) consists of 9 inlets for reagents and 
media, 1 cell loading inlet, 3 waste outlets and 6 migration chambers (Fig. 1b). The core component of this micro-
fluidic device are these 6 migration chambers (l = 1100 μ m, w = 200 μ m, hmax = 28 μ m) containing one side port 
at the middle of the long ends of the chamber while the ports at the two short ends of the chamber are connected 
to supporting sink and source channels (Fig. 1b). For controlled flow of fluids and cells all ports are equipped 
with independently controllable PDMS membrane valves. Support channels connect the reagent inlets with the 
migration chambers and the outlets. Cells can be loaded via the ports at the short ends resulting in a distribution 
along the chamber as shown in Fig. 1c. Alternatively, cells can be loaded via the ports at the long ends resulting in 
a localized distribution in the center of the chamber (Fig. 1c). The migration chambers are coated with fibronectin 
as it acts as a ligand for β 2integrins which are expressed by DCs, induce DC adhesion and therefore allow DC 
migration on a 2D surface11. Alternatively, microfluidic devices can be coated with other extracellular matrix 
proteins such as laminin13 and our platform might therefore serve for assessing the impact of other extracellular 
matrix components on immune cell or cancer cell migration.
As described earlier14,15, the flow of different molecules (e.g. chemokines) through the supporting source 
and sink channels and coordinated opening of the respective ports to individual chambers after having stopped 
fluid flow allows the generation of flow-free diffusion-based chemokine gradients in which the steepness, mean 
concentration and duration can be independently controlled. For example, spatially opposing gradients can be 
generated in parallel (Fig. 1c, chamber 1 vs. chamber 3) and the polarity or ligand type of the gradients can be 
switched when needed. As the generation of chemotactic gradients in our device is based on diffusion for mass 
transport and not fluid flow, migration characteristics of individual cells can be quantified without physical dis-
turbances of cells. Taken together, our microfluidic migration device allows tracking of individual cells with high 
spatial and temporal resolution.
For our CCL19 migration experiments, a continuously rising linear gradient was induced, reaching a 
CCL19-concentration of approximately 1.8 μ g/mL at its maximum after 2.5 hrs (Fig. 1d). Our PDMS-based 
microfluidic system with closed channels requires bonding of one channel-sustaining PDMS part to either glass 
or a second PDMS layer16. This bonding involves activation and heating steps, which preclude protein deposition 
before chamber assembly. We developed a protocol allowing protein patterning on ready-assembled chips. For 
protein patterning, we employed a photo-patterning technique to covalently surface-deposit fluorescently tagged 
molecules in arbitrary shape and, most importantly, allowing for graded intensity distributions17,18.
We patterned biotinylated fluorescein (B4F) using a focused and movable 355 nm ultra-violet laser (Fig. 2a/b). 
While laser positioning enables the generation of arbitrary B4F patterns, regulation of intensity and dwell time 
additionally allows for quantitative control of local deposition with diffraction-limited resolution. Following 
exposure, unbound B4F was washed out and chambers were filled with streptavidin (SA), which, upon binding 
to B4F, serves as an adapter for biotin-coupled reagents. Next, we loaded the chambers with the chemokine 
CCL21 carrying a c-terminal PEG-biotin tag (CCL21 24-98 bio). We used this truncated version of CCL21 to 
avoid unspecific background binding mediated by the basic c-terminal extension of full-length CCL2119. After 
washout, this yielded a surface bound CCL21 pattern, which corresponded to the initial laser pattern. The use 
of fluorescently labelled SA such as SA-Cy3 allowed visualization of printed patterns (Fig. 2c). Importantly, the 
SA-Cy3 pattern correlated closely with the amount of biotinylated CCL21 bound to SA as shown with anti-CCL21 
antibody staining (Fig. 2d).
Taken together, we reconfirm previous reports of the capability to generate highly controllable diffusion-based 
chemokine gradients in microfluidic devices14,15. We then integrated the controlled immobilization of chemok-
ines in this microfluidic device. The chemokine immobilization procedure involves several binding and washing 
steps, which are usually executed manually on a dish or cover slip. Our device not only allows patterning within 
the cell culture chamber but also enables automatization of all binding and washing steps because it features 10 
inlets for different solutions. This accelerates the procedure of protein patterning substantially.
Immobilized CCL21 gradients induce DC haptotaxis in a microfluidic migration chamber. The 
defined, surface-immobilized and bioactive CCL21 patterns and gradients obtained by LAPAP (Fig. 2c) allowed 
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Figure 1. Overview of the set up and functionality of the microfluidic migration device. (a) Photograph of 
the device with flow channels filled with blue liquid and control channels filled with red liquid. (b) Schematic 
overview of the geometry of the entire device and an individual migration chamber (inset). Flow channels are 
shown in blue, and control channels are shown in red. (c) Overview of three migration chambers loaded with 
bone marrow derived dendritic cells (upper row) and dynamics of formation of opposing diffusion-based 
gradients visualized with FITC-dextran (10 kDa) in chambers one and three. In chamber two, cell culture 
medium is exchanged as a control. (d) Diffusion profiles averaged over the centered longitudinal section of 
the chamber as a function of the location in the chamber for different times up to 150 min, with the intensity 
mapped to the concentration of FITC dextran (10 kDa) (left axis) and CCL19 (right axis). Time is colour-coded 
from blue (short times) to red (long times), with each line separated by 3.5 min.
www.nature.com/scientificreports/
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Figure 2. Manufacturing of haptotactic chemokine gradients in a microfluidic migration chamber.  
(a) Schematic of Laser Assisted Protein Adsorption by Photobleaching (LAPAP) of biotin-4-fluorescein (B4F, 
left panel) and the chemokine immobilization protocol (right panel); adapted from Schwarz & Sixt, 201635.  
(b) Schematic of laser writing into a microfluidic migration chamber. PDMS block with microfluidic chip  
(left panel). Microfluidic migration chamber with B4F gradient (enlarged region). (c) SA-Cy3 staining of 
different laser written B4F patterns in microfluidic migration chambers overlaid with the respective bright 
field image of the chamber. From left to right: chamber without pattern (‘chamber’), chamber with two printed 
patches (‘patch’) and a chamber with two gradients (‘gradient’) as used in the migration experiments (Figs 3 and 4).  
Scale bar represents 100 μ m. (d) Immunostaining of a linear CCL21 gradient printed in a migration chamber. 
SA-Cy3 image (red line and right image) and anti-CCL21/anti-goat AF 488 image (green line and left image). 
Fluorescence intensities were normalized to the respective maximum.
www.nature.com/scientificreports/
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us to quantify haptokinetic and haptotactic migration of DCs in our microfluidic device. Figure 3 illustrates 
migration of DCs in the presence and absence of immobilized CCL21. Under control conditions DCs adhere 
loosely to fibronectin-coating, show a round morphology with constant protrusions (Supplemental Movie S1, 
no chemokine) and migrate spontaneously and undirected. This is indicated by the trajectories of all cells in this 
section of the migration chamber when plotted on a common starting point (Fig. 3a; middle panel) and the dis-
tribution of directionalities as illustrated by the rose plot (Fig. 3a; right panel). In contrast to this, DCs exposed to 
a patch with a homogenous concentration of CCL21 start to adhere more tightly to the immobilized chemokine 
(Supplemental Movie S1, CCL21 patch) while migrating more efficiently but undirected (Supplemental Figure S4, 
CCL21 patch). This demonstrates the haptokinetic effect of evenly immobilized CCL21 (Fig. 3b). While expo-
sure to a gradient of immobilized CCL21 also resulted in more pronounced adherence of DCs to the substrate 
(Supplemental Movie S1, CCL21 gradient), this additionally induced directed migration of the cells towards 
higher concentrations of the gradient (Fig. 3c). This migration pattern demonstrates the haptotactic effect of 
CCL21 when immobilized as a gradient. Taken together, we show that CCL21 immobilized in our microfluidic 
device impacts on migration of DCs. Specifically, CCL21 induces chemokinesis when immobilized as a patch or 
chemotaxis when immobilized as a gradient.
CCL19 gradients induce DC chemotaxis in a microfluidic migration chamber. We have previously 
shown that chemotaxis can be induced in T cells by exposure to a soluble gradient of the chemokine CXCL12 gen-
erated in a microfluidic migration device14. To recapitulate this finding for other immune cells, we exposed DCs to 
a continuously rising gradient of CCL19 or control conditions in migration chambers of our microfluidic device 
(Fig. 4). Specifically, we loaded the DCs via the ports at the short ends of the chamber resulting in a distribution of 
the cells along the chamber. Cells adhered loosely to the fibronectin-coated PDMS surface (Supplemental Movie S2) 
with some cells starting to migrate randomly within approximately 30 min (Supplemental Movie S2, 1800 s). 
Following attachment, we exposed the cells to fresh cell-culture medium diffusing into the chamber from both 
Figure 3. DCs migrating on immobilized CCL21 24-98 bio. (a) DCs migrating in a microfluidic channel 
treated with SA-Cy3 and CCL21 24-98 bio without B4F laser-writing. (b) DCs migrating on a SA-Cy3 stained 
CCL21 24-98 bio patch printed in a microfluidic channel. (c) DCs migrating on a SA-Cy3 stained CCL21 
24-98 bio gradient printed in a microfluidic channel. Left panels: Representative images of the SA-Cy3 stained 
patterns. Middle panel: Trajectories of all cells in the respective field of view, with trajectories plotted to a 
common starting point [dimensions in μ m; time is colour-coded]. Gradient direction and pattern shape are 
indicated in grey. Right panel: Rose plot visualizing the distribution of angles of all cell tracks in an angular 
sector field with tracks split into 3 min intervals.
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Figure 4. CCL19 gradients induce DC chemotaxis in a microfluidic migration chamber. (a) DCs migrating 
in a diffusion based gradient of cell culture medium (R10). (b–d) DCs migrating in a diffusion based CCL19/
FITC dextran 10 kDa gradient. (e) Directionalities as a function of the position in the microfluidic assay for 
low (left panel) intermediate (middle panel) and high (right panel) average concentrations of CCL19. The 
zero position corresponds to the lower edge of the field of view in (b–d), where the respective concentration 
is maximal. The directionalities are shown for short, intermediate, and long times, shown in blue, green, and 
red. The concentration range covered during each period of time is indicated in the respective colour. (b) and 
www.nature.com/scientificreports/
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short ends as a control without generating a CCL19-gradient (Fig. 4a). This resulted in undirected migration of the 
cells (Fig. 4a). In parallel we exposed DCs in another migration chamber to a diffusion-based gradient of CCL19 
by sequentially refilling the channels at the top and the bottom of the microfluidic migration chamber with fresh 
medium either containing CCL19 or cell culture medium (Fig. 4b–d). This resulted in a CCL19-gradient along the 
entire chamber and accordingly to exposure of DCs to low, intermediate, or high concentrations of CCL19 over 
time as indicated by the illustration of the gradient-formation in Fig. 1d. Specifically, cells in the upper third of the 
chamber are exposed earlier and ultimately also to higher concentrations of the CCL19 gradient as compared to 
cells in the middle and particularly the lower third of the chamber. The concentration ranges during the built-up 
of the CCL19-gradient for the specific sections of the chamber are indicated in Fig. 4e. Compared to control 
cells, exposure of DCs to low concentrations (0–1.2 μ g/mL) of CCL19 resulted in faster migration (Supplemental 
Figure S4, CCL19 low) while overall migration remained undirected (Fig. 4b), reflecting the chemokinetic effect 
of the chemokine. This is in line with the with previous observations of increased migration velocity of DCs at 
comparable concentration ranges of CCL1912. The preferential distribution of tracks towards the short ends of 
the chamber relates to the fact that migration towards the long ends of the chamber is impeded by the rectangular 
geometry of the chambers. Exposure of DCs to intermediate concentrations of the CCL19-gradient (0–1.3 μ g/
ml) resulted in a significantly increased directionality of single cell trajectories towards higher concentrations of 
the chemokine (Fig. 4c). While higher CCL19-concentrations (0–1.7 μ g/ml) did not influence migration velocity 
(Supplemental Figure S4, CCL19 high), directionality was further augmented when DCs were exposed to high 
concentrations of the CCL19-gradient (Fig. 4d). This is illustrated in Fig. 4e, which shows the directionality of 
DCs in the different section of the migration chamber during the build-up phase of the CCL19 gradient as a 
function of position in the respective section and time. As shown in Fig. 4a–d, the chamber was divided into 3 
sections containing high, intermediate and low concentrations of the CCL19-gradient. These data show that DCs 
migrate in high concentrations of the chemokine gradient more directional than in intermediate concentrations 
while migration in low concentrations was non-directional. Taken together, these data indicate that directionality 
of DC migration correlated with increasing concentrations of CCL19 in the gradient. The CCL19-concentration 
in our gradients reached up to 1.7 μ g/mL (approximately 190 nM) and therefore covered the dissociation constant 
of the interaction of CCR7 with CCL19 (KD CCR7/CCL19: 10 nM–100 nM)12,20. Also, these concentrations have 
been described to sufficiently trigger downstream signalling of CCR7 following binding of CCL19 in G protein 
loading assays21 and downstream signalling assays22.
In summary, we show that diffusion-based chemokine gradients in microfluidic devices can induce directed 
migration also in DCs. The finding that directed migration in microfluidic devices can also be induced in myeloid 
cells expands previous reports on the induction of directed migration in T lymphocytes14 and emphasizes the 
potential of microfluidics for assessing biologically relevant properties on a single cell level.
Migration of DCs in competing chemotactic and haptotactic chemokine gradients. After hav-
ing shown that our microfluidic device allows exposing DCs to chemotactic and haptotactic guidance cues we 
next quantified migration of DCs simultaneously exposed to diffusion-based and immobilized chemokine gra-
dients. Specifically, we assessed migration of DCs when exposed to competing gradients of soluble CCL19 on the 
one side and immobilized CCL21 on the other side. To this end CCL21-gradients were printed into the lower 
and middle area of the migration chamber, with a maximal concentration of ca. 160 molecules/μ m2 (which, 
if related to unit volume, corresponds to a concentration of 0.24 μ g/mL, see Supplemental Figure S6). After 
washing, DCs were positioned in the chamber including the two CCL21-gradients (Supplemental Movie S3). 
After 30 min of cell recovery, an opposing diffusion-based CCL19 gradient (Supplemental Figure S5) was gener-
ated as described above. By doing so, one of the CCL21-gradients was superimposed with a low-concentration 
CCL19-gradient (CCL19low (0–1 μ g/mL)/CCL21 gradients; Fig. 5a), while the other was superimposed 
with a medium-concentration CCL19-gradient (CCL19medium (0–1.2 μ g/mL)/CCL21 gradients; Fig. 5b). 
DCs positioned in CCL19low/CCL21 gradients migrated towards higher concentrations of the haptotactic 
CCL21-gradient (Fig. 5a). Specifically, cells migrate in a haptotactic fashion towards the higher concentrations of 
the CCL21-gradient at all times as indicated by the colour code (cold colours: early time-points, hot colours: later 
time-points) in Fig. 5a. In contrast to this, DCs positioned in CCL19medium/CCL21 gradients migrated towards 
higher concentrations of the chemotactic CCL19-gradient (Fig. 5b). As for the chemotactic gradient profiles, we 
plotted the average directionalities of DCs in the CCL19low/CCL21 and the CCL19medium/CCL21 gradients 
as a function of time (Fig. 5c). These data indicate that the presence of the CCL19low/CCL21gradients induced 
preferential migration towards the haptotactic gradient. By contrast, exposure of DCs to CCL19 medium/CCL21 
gradients resulted, after build-up of the CCL19-gradient, in highly directional chemotaxis. Our findings suggest 
that haptotactic CCL21 gradients in the presence of a soluble CCL19-gradient induce directed migration only at 
low CCL19 concentrations. Increasing concentrations of the CCL19-gradient resulted in directed migration along 
the soluble gradient, while overriding the effect of the opposing haptotactic CCL21-gradient. Whether the weak 
directional response of DCs to immobilized CCL21 in the presence of a competing gradient of CCL19 relates to 
(e). 1) Lower third of the migration chamber; low CCL19 concentration regime. (c) and (e). 2) Middle third 
of the migration chamber; medium CCL19 concentration regime. (d) and (e). 3) Upper third of the migration 
chamber; high CCL19 concentration regime. Left panel: Representative images of the CCL19/FITC dextran 
10 kDa and the cell culture media (R10) gradient at t = 60 min. Middle panel: Corresponding cell track analysis 
of all tracks aligned to the origin [dimensions in μ m; time is colour-coded]. Gradient direction and pattern 
shape are indicated in grey. Right panel: Rose plot visualizing the distribution of angles of all tracks in an 
angular sector field with tracks split into 3 min intervals.
www.nature.com/scientificreports/
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the comparable binding affinities of CCL19 and CCL21 to CCR7 23,12 remains unclear. Alternatively, differences 
in the binding sites on CCR7 might cause this result. Although the overall tertiary structure of chemokines is 
highly conserved, single amino acid mutation studies have shown that activation of CCR7 by CCL19 and CCL21 
can be differentially.affected24. These data indicate that CCL19 and CCL21 mostly share their binding sites on 
CCR7 but require at least one different interaction for activating CCR7. Independent of the underlying molecular 
mechanism our setup might contribute to address questions whether and how recognition of immobilized CCL21 
differs from the recognition of soluble guidance cues.
Taken together, we show that the use of microfluidics allows superimposing chemotactic on haptotactic 
chemokine gradients and that DCs respond differentially to these guidance cues. As the characteristics of these 
soluble and immobilized chemokine gradients can be precisely controlled, this approach has the potential to 
address fundamental questions of directional cell migration.
Conclusion
Much of our understanding of directed cell migration is based on data from animal models. Some of the findings 
have been recapitulated in vitro by either chemotactic or haptotactic migration assays. These data have added sub-
stantially to our understanding of the mechanisms underlying guided cell migration. However, the likely possibil-
ity that both chemotactic and haptotactic gradients exist simultaneously in vivo was not addressed in such setups.
Figure 5. DCs migrating on opposing chemotactic CCL19 and haptotactic CCL21 gradients.  
(a) CCL19low/CCL21 area of the chamber. (b) CCL19medium/CCL21 area of the chamber. Left panel: 
Representative images of the soluble CCL19/FITC dextran 10 kDa gradient (green) after 45 min superimposed 
with immobilized CCL21/SA-Cy3 gradients (red) of the respective areas. Middle panel: Tracks of migrated DCs 
in the respective areas aligned to the origin [dimensions in μ m; time is colour-coded]. Gradient directions are 
indicated in grey. Right panel: Rose plot visualizing the distribution of angles of all tracks in an angular sector 
field (3 min intervals). (c) Directionalities as a function of the position in the channel for intermediate and low 
average concentrations of CCL19 (from left to right). Zero position corresponds to the lower edge of the field 
of view, and the directionalities are shown in blue, green, and red for short, intermediate, and long times. As in 
Figure 4, the concentration ranges per time span are indicated in the corresponding colour.
www.nature.com/scientificreports/
9Scientific RepoRts | 6:36440 | DOI: 10.1038/srep36440
The setup described here allows the generation of haptotactic gradients by photo-patterning and the flow-free 
generation and maintenance of diffusion-based gradients. Therefore, our setup allows for the first time and in 
contrast to previous reports11,12 a highly precise control of combined immobilized and soluble chemokine gra-
dients. The integration of these assays into a microfluidic device allows positioning of cells in specific regions of 
the respective gradients and assessing responses to a multitude of guidance cues in parallel. As a proof of concept 
we compared quantitatively migration characteristics of DCs on immobilized chemokine gradients with vary-
ing superimposed chemotactic gradients and found differential migratory responses. In peripheral tissues like 
skin CCL21 forms an immobilized gradient, guiding DCs towards lymphatic vessels. At the same time soluble 
CCL19 is produced mainly by cells of the hematopoietic lineage and there is indirect in vivo evidence that the 
fine-regulation of CCL19 in the skin can rate-limit DC migration25. Our finding that soluble CCL19 can override 
the immobilized CCL21-signal might suggest that CCL19 could antagonize CCL21 and serve as a local retention 
signal.
Hence, our microfluidic setup is suited to study processes in which co-existing immobilized and soluble gra-
dients impact on cell migration. In addition to immobilizing chemokines, our approach qualifies also to study 
migration characteristics of cells in haptotactic gradients of cellular adhesion sites – e.g. along gradients of 
integrin-ligands and co-existing gradients of any conceivable soluble guidance cue.
An example for co-existing immobilized and soluble chemokine gradients is the mobilization of mesenchymal 
stem cells during tissue regeneration by soluble chemokines such as CCL19 on the one side and chemokines that 
bind to extracellular glycosaminoglycans such as CCL2, CXCL12 or CCL5 on the other side26,27. Also, guided cell 
migration presumably mediated by chemotactic and haptotactic signals are of importance in the pathogenesis 
of autoimmune diseases such as multiple sclerosis (MS)28. This assumption is underlined by the fact that potent 
drugs for the treatment of MS target immune cell migration29,30. Taken together, the combination of chemo- and 
haptotactic guidance cues plays a fundamental role during various physiological processes such as protective 
immunity and tissue regeneration but also in the pathogenesis of diseases like cancer, metastasis and autoimmun-
ity. In light of the capability of our microfluidic device to control co-existing chemotactic and haptotactic guid-
ance cues and assess the migratory response of cells on a single cell level in real time our setup has the potential to 
significantly contribute to a better understanding of migration-related aspects of the above-mentioned processes.
Material and Methods
Mice. C57BL/6J mice used in this study were bred and maintained in accordance with the Austrian law for 
animal experiments (“Österreichisches Tierschutzgesetz”) and sacrificed at 4 to 10 weeks of age for use in exper-
iments. Permission and all experimental protocols were approved by the Austrian federal ministry of science, 
research and economy (identification code: BMWF-66.018/0005-II/3b/2012). All experiments were performed 
in accordance with relevant guidelines and regulations.
Chemokine. Murine CCL19 was purchased from R&D systems, USA. Biotinylated, truncated murine CCL21 
(mCCL21 24–98 bio) was synthesized by ALMAC (Craigavon, UK). Chemokines were reconstituted as follows: 
Desiccated chemokines were reconstituted to a concentration of 25 μ g/mL in PBS and stored at − 20 °C. Prior to 
use, mCCL21 24–98 bio was diluted to a working concentration of 250 ng/mL in PBS.
DyLight 594 (Thermo Fisher Scientific) labeled mCCL21 24–98 bio was prepared following the manufactur-
ers protocol. Briefly, 100 μ g mCCL21 24–98 bio were reconstituted in 100 μ L phosphate buffer containing 0.1 M 
Na2HPO4, 0.15 M NaCl adjusted to pH 7.2–7.5. 65 μ g DyLight 594 NHS ester (Thermo Fisher Scientific) were 
added and the mixture was allowed to react for 1 h at room temperature. Subsequently, excessive DyLight 594 
NHS ester was quenched for 1 h at room temperature by adding 1.4 mL of Tris/HCl pH 7.6. mCCL21 24–98 bio 
DL595 was purified using MW10 kDa spin columns (Amicon Ultra-2 Centrifugal Filter devices, Millipore) and 
stored at − 20 °C.
Quantification of surface immobilized CCL21 24–98 bio. Fluorescence intensities of a dilution 
series of mCCL21 24–98 bio DL595 (10, 2.5, 0.25 and 0.025 μ g/mL) were measured in a defined volume of a 
10 μ m high PDMS chamber (manufactured similarly as microfluidic chips) and a standard curve was calcu-
lated (Fluorescence intensity = 3443x molecules/μ m2 R2 = 0.97633). Fluorescence intensities of patches of surface 
immobilized mCCL21 24–98 bio DL595 were measured using the same imaging settings as for the dilution series. 
Immobilized mCCL21 24–98 bio DL595 concentrations were calculated from measured fluorescence intensities 
using the obtained standard curve.
Design and fabrication of microfluidic chips. The microfluidic photomask design was drawn with 
Coreldraw X6 (Corel corporation, US) and printed on transparency at a resolution of 8 μ m (JD Photo Data & 
Photo Tools, UK). A control and flow mold were produced by photo-lithography on a silicon wafer as described 
earlier with minor modifications14. In brief, the flow layer mold was spin-coated with hexamethyldisilox-
ane at 3000 rpm for 30 s and then baked at 110 °C for 1 min. Next, the wafer was spin-coated with AZ-40XT 
(Microchemicals, Germany) at 3000 rpm for 30 s and soft baked at 110 °C for 5 min. Photoresist was then exposed 
to ultra violet (UV) light for 15 min using a beam expanded 365 nm UV LED, (M365L2-C1–UV, Thorlabs GmbH, 
Germany). After UV exposure, the wafer was post-baked for 2 min at 110 °C. The wafer was developed in AZ- 
726-MIF developer for 5–7 min, rinsed in water and was then reflowed for valve closing at 110 °C for 10 min. The 
100 μ m wide parabolic AZ40XT channels had a central height of 26.3 μ m. The control layer silicon wafer mold 
was spin-coated with GM1070 SU-8 (Gersteltec, Switzerland) at 3100 rpm for 40 s to reach a final height of 25 μ m. 
The wafer was then baked for 15 min at 65 °C and then 35 min at 95 °C. The wafer was exposed for 10 min with 
the UV-LED. The post exposure bake was 15 min at 65 °C, then 45 min at 95 °C. The wafer was then developed 
in SU-8 developer (Gersteltec, Switzerland). Finally, both flow and control wafers were non-stick functionalized 
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with trichlorosilane for 1 hour in a vacuum desiccator. Microfluidic chips were fabricated by multi-layer poly-
dimethylsiloxane (PDMS) soft-lithography as described previously14,15.
Chip set-up, operation and control. The glass slide carrying the microfluidic chip was cleaned and 
taped on a slide holder. Control channels were connected to miniature pneumatic solenoid valves (Festo, 
Switzerland) that were controlled via an established control box system31 with a custom Matlab (MathWorks, 
US) graphical user interface. Optimal closing pressures of push-up PDMS membrane valves were determined 
individually for each chip the pressure in control channels was increased by 0.5 bar. Flow lines were connected 
to inlets, pressurized with 0.2–0.4 bar and the whole chip was filled with phosphate buffered saline (PBS). The 
cell culture chambers were incubated with human plasma fibronectin (c = 250 μ g/mL, Millipore, Austria) for 
1 hour while fibronectin remaining in the flow channels was flushed off the flow channels with PBS. Following 
incubation of cell culture chambers for 1 hour with fibronectin, the entire chip was flushed with cell culture 
medium for 10 min.
Generation of stable soluble chemokine gradients. Stable diffusion-based chemokine gradients were 
generated and maintained as previously described by using a switching source-sink flow pattern14,15. Briefly, the 
channels at the short ends of the cell culture chambers were sequentially refilled with fresh R10 medium (RPMI 
1640 supplemented with 10% fetal calf serum, L-Glucose and Penicillin/Streptomycin, all from Life Sciences, 
Austria) or with a mixture of murine CCL19 (2.5 μ g/mL in R10; R&D systems USA) and FITC-dextran 10 kDa 
(200 μ g/mL in R10; hydrodynamic radius: 2.3 nm; Sigma Aldrich, US). By doing so, a local high concentration 
(source) and a low concentration (sink) is established between which a chemokine gradient is built up and main-
tained by diffusion. We used FITC-dextran as a proxy to monitor the chemokine gradient within the chamber. 
The diffusion profiles of FITC-dextran 10 kDa and the chemokines CCL19 and CCL21 are expected to be very 
similar for similar hydrodynamic radii. These radii can be estimated empirically32 and read (1.7 + /− 0.4) nm for 
CCL19 (9 kDa) and (1.9 + /− 0.4) nm for CCL21 (12.5 kDa), which is comparable to the 2.3 nm of FITC.
Generation of bound chemokine gradients by laser-assisted adsorption by photobleaching. 
For on-chip chemokine patterning, each chamber was washed with PBS for 10 s to remove unbound fibronectin. 
Next, chambers were filled with biotin-4-fluorescein (B4F, 150 μ g/mL, Sigma Aldrich, US) and patterns were 
written using a steerable, pulsed UV laser (λ = 355 nm) Specifically, a long working distance 20x objective (Zeiss 
LD Plan Neo 20 × 0.4) focused the UV laser at the interface between the bottom of the microfluidic chamber and 
the B4F. A custom program controlled a pair of high-speed galvanometric mirrors that moved the focus spot 
within the chamber. The gradient pattern was specified by an image whose pixel values determined the light dose 
used for bleaching. Careful calibration allowed compensating for the off-center drop of numerical aperture of 
the objective as well as the geometric distortions arising from the imperfect imaging of the scan mirrors into the 
back aperture of the objective. Hence, the full field of view of the objective could be utilized for gradient writing. 
For each spot, the total light dose was split up into multiple laser pulses in order to average out the pulse-to-pulse 
power variability of the laser. The gradient was written into the bottom of the chambers one spot at a time with 
the scanning mirrors moving the laser focus by about half the diameter of the focus spot in order to create a con-
tinuous pattern. The low wavelength of the UV laser resulted in a high lateral resolution (~0.7 μ m) and the low 
crosstalk to a high dynamic range (~100:1) of the gradient pattern. The writing speed was limited by the laser’s 
pulse frequency of 1 kHz. A full description of the hardware employed can be found in Behrndt et al.33. Following 
laser writing, the chamber was washed with PBS for 10 s and subsequently incubated for 20 min at room temper-
ature with streptavidin-Cy3 (SA-Cy3, 10 μ g/mL in PBS with 3% BSA, Sigma Aldrich, US). After 10 s of washing 
with PBS, the chamber was incubated for 30 min at 37 °C with biotinylated CCL21 (CCL21 24–98 bio; custom 
synthesized, 250 ng/mL in PBS, Almac, UK). Apart from loading steps, the supporting source and sink channels 
were kept constantly under flow with PBS (0.2 bar) to reduce unspecific adsorption of any reagent outside the cell 
culture chambers. Following washing for 10 s with PBS the DC suspension (10 × 106 cells/mL in R10 medium) 
was loaded into the cell culture chambers.
The concentration of immobilized CCL21 was quantified indirectly by measuring the intensities of different 
concentrations of soluble CCL21 bio with molecular weight 9080 Da in a given volume of the chamber. These 
intensities were then matched to the amount of molecules in that volume. As intensities are seen as a projection 
across the height of the chamber, the intensities observed can be mapped to the number of CCL21 molecules per 
unit area. The maximal intensity observed for immobilized CCL21 then corresponds to (157 ± 33) molecules/μ m2 
(Supplemental Figure S6).
Dendritic cell isolation, culture and maturation. DCs were generated from bone marrow cells 
extracted from femur and tibia of C57BL6 mice. In brief, bone marrow cells were collected by spinning distally 
capped bones in an upright position with 4500 rpm for 5 min. Next, 2 × 106 bone marrow cells were cultured 
in 10 mL R10 medium containing 1 mL supernatant from a granulocyte-macrophage colony-stimulating fac-
tor (GM-CSF) hybridoma cell line in a non-adhesive petri dish. On day 4, 10 mL of R10 medium containing 
2 mL supernatant from a GM-CSF hybridoma cell line were added. On day 7, 10 mL of cell culture medium was 
replaced by 10 mL of R10 medium containing 2 mL supernatant from a GM-CSF hybridoma cell line. DCs were 
harvested on day 8–10 of the culture and maturated overnight with lipopolysaccharide (LPS, 200 ng/mL).
Imaging, Cell-tracking and data analysis. Cells were imaged using an automated inverted microscope 
(Nikon Ti, 10 × /NA 0.3 Air Plan Fluor Ph1 and 20 × /NA 0.5 Air Plan Fluor Ph1 objective; Nikon, Japan) equipped 
with a stage-top incubator controlling for temperature (37 °C), CO2-concentration (5%) and humidity (90%), a 
digital EMCCD camera (EMCCD C9100–02; Hamamatsu photonics, Japan) and the imaging software Nikon 
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:36440 | DOI: 10.1038/srep36440
NIS-AR (Nikon, Japan). For evaluation of migration properties, cells were tracked in an area of 300 × 200 μ m, 
which corresponds to the size of the chemokine pattern. Cell tracks are represented on an x-y coordinate system, 
with the origin of each trajectory aligned to (0,0). Each track is colour-coded for time, such that cold colours 
represent early and hot colours later time points. For image processing and cell tracking, Fiji34 and a plugin for 
manual tracking (“Manual Tracking”, Cordelieres 2005) were used. Images and tracking data were analyzed using 
Matlab 2013 (MathWorks Inc., US).
Statistical analysis. From cell tracks, the direction of the cells was calculated through the angle Θ between 
the direction of the respective gradient and the (current) cell direction. The direction of each cell was determined 
every 3 min. This time interval was chosen so that most cells have moved by roughly their typical diameter. 
Events, without any motion, were excluded from the analysis. The overall directionality of cells is then given by 
< cos(Θ)> , where the average is over both time and location of the cells, with time spans and regions as indicated 
in the main text. Error bars represent the standard deviation of < cos(Θ)> determined with a bootstrapping 
method, where we resampled 200 times with the original sample size.
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